Four countries shed light on drug-review policies.
Young
Donna
D
D002170:Canada; D003362:Cost-Benefit Analysis; D017277:Drug Approval / Q000458:organization & administration*; D017850:Economics, Pharmaceutical; D005858:Germany; D006291:Health Policy; D006801:Humans; D007391:International Cooperation; D006113:United Kingdom; D014481:United States